NOVELLUS VENTURES LS1 GP, LLC
NOVELLUS VENTURES LS1 GP, LLC is a Pre-seed, Seed and Series A fund in the US investing in AI, Healthcare, life-sciences, healthcare-tech, diagnostics and therapeutics.
- Stages
- Pre-seed, Seed, Series A
- Sectors
- AI, Healthcare, life-sciences, healthcare-tech, diagnostics, therapeutics
- Invests in
- US-wide
- Actively investing
- Yes
- Founded
- 2025
- Website
- novellusventures.com
Check size not disclosed
Thesis
Novellus Ventures is an early-stage venture capital firm founded in 2025 and based in Houston, Texas. The firm focuses on North American companies in life sciences and health technology, particularly those using AI to improve diagnostics, med-tech, therapeutics, and digital health. They partner with founders of pre-seed, seed, and Series A companies, offering strategic support beyond capital. While specific fund sizes and AUM are undisclosed, the Novellus Ventures LS1 Fund, L.P. was established in 2025. The firm aims to be a catalyst for innovation in healthcare, bringing groundbreaking technologies to market.
Common questions
Does NOVELLUS VENTURES LS1 GP, LLC invest at the Pre-seed stage?
Yes. NOVELLUS VENTURES LS1 GP, LLC lists Pre-seed, Seed and Series A among the stages it invests in.
Where does NOVELLUS VENTURES LS1 GP, LLC invest?
NOVELLUS VENTURES LS1 GP, LLC invests in the US.